<div id="readability-page-1"><p>Hunter Perkins Capital Management LLC purchased a new position in shares of  Align Technology, Inc. (NASDAQ:ALGN - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 9,075 shares of the medical equipment provider's stock, valued at approximately $1,136,000.</p><div><p><span></span><span>Get <strong>Align Technology</strong> alerts:</span></p></div><ul><li>Why These 3 Tech Stocks Could Be the Best Opportunities You're Overlooking</li></ul><p>Several other large investors also recently modified their holdings of ALGN. Czech National Bank raised its holdings in  Align Technology by 3.3% in the second quarter. Czech National Bank now owns 16,654 shares of the medical equipment provider's stock valued at $3,153,000 after acquiring an additional 537 shares in the last quarter.  QRG Capital Management Inc. bought a new position in  Align Technology during the 2nd quarter worth approximately $306,000.  Envestnet Portfolio Solutions Inc. raised its position in shares of  Align Technology by 4.5% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 2,372 shares of the medical equipment provider's stock valued at $449,000 after acquiring an additional 102 shares in the last quarter.  Navera Investment Management Ltd. boosted its holdings in  Align Technology by 3.0% in the second quarter. Navera Investment Management Ltd. now owns 787,559 shares of the medical equipment provider's stock worth $149,126,000 after purchasing an additional 23,080 shares during the period.  Finally, Franklin Resources Inc. increased its stake in  Align Technology by 115.6% during the second quarter. Franklin Resources Inc. now owns 17,432 shares of the medical equipment provider's stock valued at $3,300,000 after purchasing an additional 9,345 shares during the last quarter. 88.43% of the stock is currently owned by institutional investors and hedge funds. </p><h2>Analysts Set New Price Targets</h2><p>ALGN has been the topic of several research reports. Wells Fargo &amp; Company dropped their price objective on shares of Align Technology from $199.00 to $181.00 and set an &#34;overweight&#34; rating on the stock in a research note on Thursday, October 30th. Piper Sandler  reiterated an &#34;overweight&#34; rating and issued a $200.00 target price (up from $190.00) on shares of Align Technology in a research note on Thursday, October 30th. Needham &amp; Company LLC  restated a &#34;hold&#34; rating on shares of Align Technology in a research report on Thursday, October 30th. Evercore ISI reduced their target price on shares of Align Technology from $220.00 to $170.00 and set an &#34;outperform&#34; rating for the company in a research note on Tuesday, November 25th. Finally, Barclays began coverage on shares of Align Technology in a research report on Monday, December 8th. They issued an &#34;equal weight&#34; rating and a $170.00 target price for the company. One analyst  has rated the stock with a Strong Buy rating, six have assigned  a Buy rating, eight have given a Hold rating and one  has issued  a Sell rating to the company's stock. Based on data from MarketBeat.com, Align Technology  has an average rating of &#34;Hold&#34; and an average price target of $172.18.</p><ul><li>Buy the Dip? These Earnings Misses Offer Long-Term Upside</li></ul><p><b>Read Our Latest Research Report on ALGN</b></p><h2>Align Technology Price Performance</h2><p>NASDAQ ALGN opened at $156.45 on Thursday. The company has a market capitalization of $11.22 billion, a P/E ratio of 30.32, a PEG ratio of 1.91 and a beta of 1.86. Align Technology, Inc. has a 12 month low of $122.00 and a 12 month high of $237.23. The company's 50 day simple moving average is $145.16 and its 200 day simple moving average is $153.75. </p><ul><li>MarketBeat Week in Review: 12/25 - 12/29</li></ul><p>Align Technology (NASDAQ:ALGN - Get Free Report) last announced its quarterly earnings data on Wednesday, October 29th. The medical equipment provider reported $2.61 EPS for the quarter, beating analysts' consensus estimates of $2.38 by $0.23. The company had revenue of $995.69 million during the quarter, compared to the consensus estimate of $980.75 million. Align Technology had a return on equity of 13.96% and a net margin of 9.50%.The company's quarterly revenue was up 1.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.35 EPS.  On average, analysts anticipate that  Align Technology, Inc. will post 7.98 earnings per share for the current year. </p><h2>About Align Technology</h2> (Free Report)<p>Align Technology, Inc <span>NASDAQ: ALGN<span></span></span> pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.  </p><p>The company's signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.</p><h2>See Also</h2><ul><li>Five stocks we like better than Align Technology</li><li>Do not delete, read immediately</li><li>INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off</li><li>Can Any Expenses Be Deducted From Capital Gains Tax?</li><li>Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why</li><li>Forget AI, This Will Be the Next Big Tech Breakthrough</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxHTg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxHTg"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Align Technology Right Now?</h2><p>Before you consider Align Technology, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Align Technology wasn't on the list.</p><p>While Align Technology currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

ALGN

<p>Hunter Perkins Capital Management LLC acquired 9,075 shares of Align Technology, Inc. valued at approximately $1,136,000 during the 3rd quarter. Align Technology, a medical equipment provider, reported a quarterly EPS of $2.61, surpassing estimates. The company's stock has an average rating of 'Hold' with a target price of $172.18. Align Technology's market cap is $11.22 billion, with a P/E ratio of 30.32. Institutional investors own 88.43% of the stock.</p>

Hunter Perkins Capital Management LLC Takes Position in Align Technology, Inc. $ALGN